Results 21 to 30 of about 5,691,277 (301)

The medicalization of cannabis [PDF]

, 2010
Cannabis has been considered as both an illicit drug and a medicine throughout its history. Introduced to the UK as a medicine in the nineteenth century, its medical utility was limited and it was not until tetrahydrocannabinol (THC), one of the ...
Crowther, SM, Reynolds, LA, Tansey, EM
core   +6 more sources

Associations between cigarette smoking and cannabis dependence: a longitudinal study of young cannabis users in the United Kingdom. [PDF]

, 2015
To determine the degree to which cigarette smoking predicts levels of cannabis dependence above and beyond cannabis use itself, concurrently and in an exploratory four-year follow-up, and to investigate whether cigarette smoking mediates the relationship
Gale, G, Hindocha, Chandni, Schafer, G, Morgan, Celia J A, Falconer, CJ, Curran, H Valerie, Morgan, CJ, Das, Ravi K, Shaban, Natacha D C, Hindocha, C, Gale, Grace, Das, RK, Curran, HV, Shaban, ND, Freeman, Tom P; id_orcid, Falconer, Caroline J, Schafer, Grainne, Freeman, TP   +17 more
core   +1 more source

Medical cannabis in the UK [PDF]

BMJ, 2018
Patients should not be criminalised for seeking benefits: Do patients have the right to medicate themselves, or should they be punished for doing so? Should their doctors work with them to decide on the best treatment, or does the government know best? These questions are at the heart of the current debate on the use of cannabis as medicine. In the
openaire   +3 more sources

The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

, 2021
Background Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety ...
Flood, John, Lewis, Monique, Monique Lewis, John Flood   +3 more
core   +1 more source

Medical cannabis identity and public health paternalism

Public Health in Practice, 2023
Objectives: State-dependent and variable lists of medical conditions granting access to medical cannabis in the United States may be an example of public health paternalism.
Amanda Reiman, Joshua S. Meisel, Rielle Capler, Darcey Paulding McCready   +3 more
doaj   +1 more source

Medical cannabis and cannabidiol: A new harvest for Malawi [PDF]

, 2022
In February 2020 parliament passed the Cannabis Regulation Bill (2020) which regulates the cultivation and production of industrial hemp and medical cannabis.
Bandawe, Gama, Gama Bandawe
core   +1 more source

Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution

Journal of Cannabis Research, 2021
Background People report using cannabis as a substitute for prescription medications but may be doing so without the knowledge of their primary health care providers (PCPs). This lack of integration creates serious concerns, e.g., using cannabis to treat
Kevin F. Boehnke, Evangelos Litinas, Brianna Worthing, Lisa Conine, Daniel J. Kruger   +4 more
doaj   +1 more source

Protocol: mixed-methods study of how implementation of US state medical cannabis laws affects treatment of chronic non-cancer pain and adverse opioid outcomes

Implementation Science, 2021
Background Thirty-three US states and Washington, D.C., have enacted medical cannabis laws allowing patients with chronic non-cancer pain to use cannabis, when recommended by a physician, to manage their condition.
Emma E. McGinty, Kayla N. Tormohlen, Colleen L. Barry, Mark C. Bicket, Lainie Rutkow, Elizabeth A. Stuart   +5 more
doaj   +1 more source

Shifts in medical cannabis use in Canada during the COVID-19 pandemic

Health Promotion and Chronic Disease Prevention in Canada, 2023
IntroductionThe COVID-19 pandemic has had widespread secondary negative health impacts including loss of material security and exacerbation of mental illness in at-risk populations.
Stephanie Lake, Ziva D. Cooper, Kaye Ong, Philippe Lucas   +3 more
doaj   +1 more source

Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study

Gynecologic Oncology Reports, 2020
Research within a gynecologic oncology population has lagged behind the uptake in use of medical cannabis for symptom control. This study seeks to evaluate patient experience with prescribed medical cannabis obtained through licensed dispensaries in ...
Emily M. Webster, Ghanshyam S. Yadav, Stefan Gysler, Blair McNamara, Jonathan Black, Joan Tymon-Rosario, Burak Zeybek, Chanhee Han, Christopher K. Arkfeld, Vaagn Andikyan, Gulden Menderes, Gloria Huang, Masoud Azodi, Dan-Arin Silasi, Alessandro D. Santin, Peter E. Schwartz, Elena S. Ratner, Gary Altwerger   +17 more
doaj   +1 more source